Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Current and future options in the management and treatment of uterine sarcoma:

Current and future options in the management and treatment of uterine sarcoma: Uterine sarcomas are rare aggressive mesenchymal tumours with limited prognosis. They encompass various histological subtypes such leiomyosarcoma, endometrial stromal sarcoma and undifferentiated sarcomas with different surgical and medical strategies. Current evidence of surgery, adjuvant and palliative therapy is reported. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Therapeutic Advances in Medical Oncology SAGE

Current and future options in the management and treatment of uterine sarcoma:

Loading next page...
 
/lp/sage/current-and-future-options-in-the-management-and-treatment-of-uterine-1jHloZYUQm
Publisher
SAGE
Copyright
Copyright © 2020 by SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
ISSN
1758-8359
eISSN
1758-8359
DOI
10.1177/1758834013513314
Publisher site
See Article on Publisher Site

Abstract

Uterine sarcomas are rare aggressive mesenchymal tumours with limited prognosis. They encompass various histological subtypes such leiomyosarcoma, endometrial stromal sarcoma and undifferentiated sarcomas with different surgical and medical strategies. Current evidence of surgery, adjuvant and palliative therapy is reported.

Journal

Therapeutic Advances in Medical OncologySAGE

Published: Dec 17, 2013

Keywords: chemotherapy,endometrial stromal sarcoma,surgery,uterine leiomyosarcoma,uterine sarcoma

There are no references for this article.